abstract |
The present invention relates to a B cell vaccine and its use, and more particularly, the present invention relates to a B cell vaccine and a method for stimulating long-term naïve CD8 T cells through the use of genetically modified B cells over- And can provide prophylactic or therapeutic effects of tumors, pathogen infection or autoimmune diseases through co-expression of CD40L molecules with CD70, OX40L or 4-1BBL in B cells. |